Medical Device Injection Molding Case Studies: CTQ, Validation & Quality Evidence

CTQ Control, Material Traceability, Inspection Records & Validation Support

Medical injection molding case evidence showing CTQ inspection, material traceability and validation documentation review

These medical device injection molding case studies show how engineering and sourcing teams can review critical-to-quality features, material traceability, dimensional inspection, process risks and validation-support records before supplier approval or tooling release.

The cases include catheter connectors, drug-delivery housings and two-shot syringe components where sealing surfaces, fit-critical interfaces, thin-wall geometry, overmold boundaries and traceability requirements must be evaluated using DFM input, CMM or optical inspection, FAI records, material certificates, CoC records and trial-stage evidence where specified.

For broader material, tooling, supplier-qualification and documentation considerations, review our medical plastic injection molding requirements . For production capabilities beyond these cases, see our injection molding services .

Request Medical Molding DFM Review Quality Documents and Inspection Support

Case Evidence Overview

Summary of medical injection molding case projects, CTQ requirements, inspection methods and evidence reviewed.
Case Project Resin / Process Review Critical-to-Quality Focus Inspection Method Evidence to Review
Catheter Connector Medical-grade resin and overmolding compatibility review Sealing diameter, tubing-retention area, overmold interface and leak-path risk Dimensional inspection, interface review and leak or pressure verification where specified FAI Trial Record Material Cert
Drug Delivery Housing Resin behavior, thin-wall stability and sterilization-sensitive geometry review Sealing-face flatness, snap-fit position, micro-feature definition and assembly alignment Optical measurement, CMM inspection, feature review and drawing-based FAI where required Material Cert CoC FAI
Safety Syringe Component Two-shot molding review for rigid-soft interface and shot-to-shot alignment Interface locking consistency, flash control, assembly fit and material traceability boundary Assembly-force check, fit verification, interface inspection and traceability review Lot Traceability Validation Support CoC

Case Study 1: Catheter Connector Overmolding with Sealing Interface Control

Catheter connector overmolding case showing sealing interface, tubing retention geometry and overmold coverage review
Sealing interface, tubing-retention geometry and overmold coverage reviewed as CTQ features.

Project Background & Functional Risk

This catheter connector program involved a disposable medical component with a molded connection interface and overmolded grip area. The engineering review focused on fluid-path sealing, tubing retention, overmold consistency and material compatibility because variation in these areas could affect assembly fit and functional reliability.

Critical-to-Quality Features Reviewed

Before tooling release, the project review separated the functional interfaces from general cosmetic dimensions and identified the following areas as Critical-to-Quality (CTQ):

  • Sealing Diameter: mating diameter, roundness and datum relationship were reviewed against drawing tolerance and interface intent.
  • Barb & Tubing-Retention Geometry: edge definition, pitch consistency and flash-sensitive areas were included in the dimensional and molding review.
  • Overmold Coverage: circumferential coverage, knit-line position, flash, void risk and incomplete-fill areas were treated as functional rather than cosmetic concerns.
  • Retention Verification: any pull-off or mechanical-retention acceptance criteria remained tied to the customer-defined test method and specification.
Catheter connector inspection fixture used to review sealing interface and leak-path verification requirements
Inspection-fixture concept for sealing-interface and leak-path verification based on customer requirements.

Material & Process Decisions

The process review covered substrate and overmold material compatibility, resin conditioning, bonding-interface condition, gate and venting strategy, flash-sensitive areas and the handling boundary for traceable production records. Sterilization-related material or geometry requirements were treated as customer-defined inputs rather than assumed by the molding supplier.

Inspection & Evidence Package

The inspection plan linked drawing dimensions to the connector's functional interfaces. Instead of treating every dimension with the same priority, the evidence package concentrated on sealing, tubing retention, overmold coverage and traceability.

  • Dimensional FAI: sealing diameter, barb geometry, interface dimensions, overmold coverage and drawing-revision status were included in the first-article review.
  • Sealing / Leak-Path Verification: test method, acceptance limits and record format remained customer-defined wherever functional leak or pressure verification was specified.
  • Material & Lot Traceability: resin lot, material certificate, cavity identification, process-change status and drawing revision could be linked through the required manufacturing records.
  • Trial-Stage Records: tooling observations, flash or coverage issues and corrective actions could be retained as part of the trial-history and supplier-qualification package.
Primary CTQ Sealing diameter, tubing-retention geometry and overmold interface
Inspection Focus Dimensional FAI, interface inspection and customer-defined leak verification
Traceability Material lot, cavity, revision and process-change linkage
Engineering Lesson Functional interfaces should be defined before tooling and process decisions are frozen
Evidence boundary: Functional acceptance criteria, leak-test limits, sterilization requirements and device-level validation remain customer-defined. SPI's scope is manufacturing feasibility, tooling and molding review, inspection support, traceability records and agreed validation-support documentation.

Case Study 2: Thin-Wall Drug Delivery Housing with Micro-Feature & Fit Control

Drug delivery housing under optical inspection for thin-wall geometry, micro features, snap fits and CTQ review
Optical inspection of micro-features, snap-fit areas, sealing-face geometry and thin-wall molding conditions.

Project Background & Dimensional Risk

This medical molding case involved a drug delivery housing with thin-wall sections, micro-features, snap-fit interfaces and fit-critical alignment surfaces. Because these features influence mechanism alignment, assembly fit and sealing-face stability, the project review concentrated on dimensional shift, warpage, short-shot risk, flash and cumulative tolerance stack-up before tooling release.

Critical-to-Quality Features Reviewed

The engineering review identified the following Critical-to-Quality (CTQ) areas so the tooling, molding and inspection plan could remain focused on functional risk rather than cosmetic appearance alone.

  • Sealing Face & Snap Fits: sealing-surface flatness, snap-fit engagement and interface location were linked to the drawing datum scheme and assembly intent.
  • Micro Ribs & Alignment Bosses: small or high-aspect-ratio features were reviewed for incomplete fill, flash, gas-trap and feature-definition risk.
  • Tolerance Stack-Up: mating dimensions were reviewed together so an individual dimensional pass would not hide an assembly-alignment problem.
  • Warpage & Shrinkage: wall-thickness transition, gate location, resin behavior and cooling balance were included in the tooling-risk review.

Tooling & Process Risks Reviewed

The tooling review concentrated on the areas most likely to affect thin-wall filling and micro-feature repeatability: gate location, venting, thermal balance, resin flow and access for CTQ inspection.

  • Gate & Flow Path: gate location and flow-front direction were reviewed against thin-wall sections, snap-fit areas and micro-feature filling.
  • Venting: rib ends, bosses, sealing regions and flow-end areas were treated as priority locations for gas-trap and short-shot risk review.
  • Trial-Stage Process Review: molded samples, defect observations and CTQ inspection feedback were used to judge whether tooling or process correction was required before production-intent review.
DFM Review for Thin-Wall & Micro-Feature Molding

Inspection, Traceability & Sterilization Boundary

The inspection plan connected micro-feature geometry with assembly and interface risk. Optical measurement, CMM or fixture-based checks were selected according to feature accessibility, datum structure and drawing requirements, with dimensional FAI and material traceability supporting the documented review.

  • Optical Inspection: used for small-feature definition, flash-sensitive areas, snap-fit geometry and visually accessible CTQ features.
  • Dimensional Metrology: CMM, optical measurement or fixture-based checks were matched to datum logic and feature accessibility rather than using one inspection method for every feature.
  • Sterilization Boundary: EtO, gamma, autoclave or other post-process effects were not assumed by the molding supplier; sterilization method and any dimensional recheck requirement remained customer-defined.
  • Documentation: supporting records could include dimensional FAI, material certificate, CoC, trial-stage notes, traceability records and capability data only where supported by actual project records.
Tolerance Feasibility for Fit-Critical Molded Features
Case Review Area Primary Risk Evidence / Inspection Focus
Thin-Wall Geometry Short shot, warpage, uneven packing and dimensional shift near thin sections DFM notes, trial samples, dimensional inspection and tooling / process review
Micro Features Incomplete fill, flash, gas trap and weak feature definition Optical inspection, feature images, FAI notes and trial-stage issue tracking
Fit-Critical Interfaces Tolerance stack-up, datum mismatch, snap-fit variation and assembly-alignment risk CMM, optical measurement, fixture checks, drawing revision control and tolerance review
Engineering Lesson A visually acceptable molded part can still fail at a functional interface CTQ definition, inspection method, material traceability and customer-defined acceptance requirements should be established before tooling release
Evidence boundary: Device-level validation, sterilization qualification and final functional acceptance remain within the customer's defined specification and regulatory scope. SPI's role is limited to the agreed tooling, molding, dimensional inspection, traceability and manufacturing-documentation support.

Case Study 3: Two-Shot Medical Component with Rigid-Soft Interface Control

Two-shot medical component molding case showing rigid-soft interface alignment and process-control review
Two-shot molding review focused on interface alignment, material transition and repeatability risk.

Project Background & Interface Risk

This medical molding case involved a syringe-related multi-material component using a rigid body and a soft functional interface. The primary engineering challenge was controlling shot-to-shot positioning, rigid-soft transition quality, flash-sensitive features, material compatibility and assembly-fit consistency rather than simply producing two materials in one molded part.

Critical-to-Quality Features Reviewed

  • Interface Alignment: shot-to-shot positioning and transfer alignment were reviewed to reduce registration mismatch and flash at the material transition.
  • Locking Features: functional engagement surfaces were linked to drawing datums, assembly intent and customer-defined acceptance criteria.
  • Soft-Material Properties: hardness and surface characteristics remained tied to the approved material specification rather than subjective tactile judgment alone.
  • Rigid-Soft Interface: compatibility, bond-line continuity, flash, short shot, peeling risk and visible interface defects were included in the CTQ review.
  • Assembly Function: retention, locking engagement or release behavior remained subject to the customer-defined test method and sampling requirement.
Two-shot medical component detail showing rigid-soft transition, locking feature and flash-sensitive interface
Rigid-soft transition, locking feature and flash-sensitive interface reviewed as functional CTQs.

Two-Shot Process-Control Review

The process review concentrated on interface repeatability, material pairing, part transfer or positioning consistency, insert orientation where applicable, and the relationship between molding conditions and the defined CTQ features.

  • Positioning & Error Prevention: fixture logic, sensing or mechanical poka-yoke could be incorporated where the approved process required protection against wrong orientation or interface mismatch.
  • Trial-Stage Review: molding observations and CTQ inspection feedback were used to assess fill balance, interface stability, flash and dimensional repeatability before production-intent approval.
  • Monitoring Strategy: vision inspection, dimensional checks, part-weight checks or other controls could be selected according to the approved control plan, CTQ risk and equipment capability.

Inspection, Traceability & Change Control

The documentation plan connected part function with material traceability, interface inspection and revision control. This was particularly important because changes to tooling, material or process conditions could affect both dimensional alignment and rigid-soft interface performance.

  • Assembly Verification: locking engagement, retention, release behavior or other functional checks remained tied to the defined customer sampling and acceptance method.
  • Dimensional & Visual Inspection: CMM, optical measurement, fixture checks or vision inspection were selected according to feature accessibility, datum logic and drawing requirements.
  • Lot & Revision Tracking: material lot, cavity, tooling revision, process-change status and drawing revision could be linked through the agreed traceability records.
  • Engineering Change Control: tooling, material, process or acceptance-criteria changes required documented review before release under the agreed production control plan.
Primary CTQ Rigid-soft interface alignment, flash control and locking-feature consistency
Process Focus Shot-to-shot positioning, material pairing and interface repeatability
Traceability Material lot, cavity, tooling revision and drawing-revision linkage
Engineering Lesson Multi-material molding must control the interface, not only the two individual materials
Evidence boundary: SPI supports tooling and molding review, dimensional inspection, traceability planning, change-control records and agreed process-validation documentation. Device-level clinical validation, sterilization validation, regulatory submission and legal-manufacturer responsibility remain within the OEM or legal manufacturer's scope.

Medical Molding Responsibility Boundaries: SPI vs. OEM

Medical injection molding programs require a clear distinction between manufacturing support and final medical-device regulatory responsibility. SPI supports the agreed tooling, molding, inspection, traceability and manufacturing-documentation scope, while device-level regulatory and clinical responsibility remains with the OEM or legal manufacturer.

SPI Manufacturing Support OEM / Legal Manufacturer Responsibility
Manufacturing Evidence
  • Tooling and molding feasibility review against defined drawing, CTQ and process requirements.
  • In-process and final dimensional inspection against agreed drawings, datums and inspection plans.
  • Material-lot, production-lot, cavity, drawing-revision and process-change traceability where specified.
  • FAI, dimensional reports, material certificates, CoC and agreed manufacturing records.
  • Process-validation documentation support where specifically defined by the customer program.
Regulatory & Device Control
  • Final device design ownership, intended use and device-level risk management.
  • FDA, EU MDR or other applicable regulatory submissions, registrations and approvals.
  • Clinical validation, device-level verification and final product safety claims.
  • Sterilization validation, biocompatibility assessment and end-use qualification.
  • Labeling, post-market surveillance and legal manufacturer obligations.
Scope clarification: The exact manufacturing, inspection and documentation package is defined by the customer's drawing, quality agreement, purchase requirements and approved project scope. SPI does not represent device-level regulatory approval or legal-manufacturer responsibility.

FAQ About Medical Injection Molding Case Reviews & RFQ Preparation

What files should be submitted before a medical injection molding RFQ?

A useful RFQ package normally includes a 3D CAD model, revision-controlled 2D drawing, resin requirement, annual volume, tooling intent and clearly marked Critical-to-Quality features.

For medical components, it is especially helpful to identify sealing surfaces, fit-critical interfaces, micro-features, overmold boundaries, inspection requirements and any customer-defined traceability or post-process conditions before DFM and quotation review.

What evidence can buyers review before supplier approval?

Buyers can review evidence that connects the drawing and functional CTQs with tooling decisions, inspection methods and manufacturing records.

Depending on the agreed project scope, this may include DFM notes, trial-stage records, dimensional FAI, CMM or optical inspection results, material certificates, CoC, lot traceability and revision-controlled manufacturing documents. Any performance or capability claims should be supported by actual project records.

What kinds of medical components are suitable for injection molding?

Injection molding is commonly suitable for repeatable plastic components such as catheter connectors, fluid-delivery interfaces, drug-delivery housings, snap-fit assemblies, overmolded parts and other production-volume components with stable geometry and defined material requirements.

Suitability depends on more than part type alone. Resin, annual volume, tolerance feasibility, CTQ definition, tooling strategy and inspection requirements should all support the intended production route.

When is production injection molding not the right first step?

Production tooling is usually premature when the CAD design, mating interfaces, resin choice, CTQs or expected production volume are still changing.

In those situations, CNC machining, 3D printing, vacuum casting, prototype tooling or bridge tooling may offer a lower-risk path for fit checks and design iteration before committing to a production mold.